Skip to content
HowShorted

Oric Pharmaceuticals, Inc. short interest in 2026

In 2026, Oric Pharmaceuticals, Inc.'s disclosed short interest ran from 21.70% of shares outstanding on 15 Jan 2026 to 16.91% on 15 Sep 2026, a change of -4.79 percentage points. The year's high was 22.23% on 30 Jan 2026 and its low 16.66% on 31 Aug 2026, averaging 20.42% across 17 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 19.13 days on 13 Feb 2026. Full history: Oric Pharmaceuticals, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Oric Pharmaceuticals, Inc. in 2026

2026 in figures

Start of year
21.70% (15 Jan 2026)
End of year
16.91% (15 Sep 2026)
Change
-4.79 pp
High
22.23% (30 Jan 2026)
Low
16.66% (31 Aug 2026)
Average
20.42%
Highest days to cover
19.13 (13 Feb 2026)
SEC filings marked
6

Every report in 2026

Oric Pharmaceuticals, Inc. short interest in 2026
SettlementShort interestDays to coverFilings since previous
15 Jan 202621.70%10.80
30 Jan 202622.23%12.79
13 Feb 202622.02%19.13
27 Feb 202621.72%13.0210-K filed, results (8-K)
13 Mar 202620.58%12.04
31 Mar 202619.28%12.86
15 Apr 202620.67%5.68
30 Apr 202621.26%16.60
15 May 202621.20%15.3910-Q filed, results (8-K)
29 May 202621.19%17.24
15 Jun 202620.34%10.31
30 Jun 202621.36%12.32
15 Jul 202621.30%13.53
31 Jul 202621.04%13.55
14 Aug 202617.74%10.9610-Q filed, results (8-K)
31 Aug 202616.66%16.16
15 Sep 202616.91%14.21

See also: Oric Pharmaceuticals, Inc.'s full history · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.